Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CRMD
CorMedix Inc.
stock NASDAQ

Market Open
Aug 5, 2026 2:21:58 PM EDT
7.47USD-0.466%(-0.04)239,883
7.47Bid   7.48Ask   0.01Spread
Pre-market
Aug 5, 2026 9:27:30 AM EDT
7.46USD-0.666%(-0.05)2,451
After-hours
Aug 4, 2026 4:38:30 PM EDT
7.59USD+1.065%(+0.08)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 4, 2022
08:00AM EST  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will be participating in several upcoming investor conferences in January.   GlobeNewswire Inc
Nov 9, 2021
06:06PM EST  Cormedix Q3 EPS $(0.22) Misses $(0.18) Estimate, Sales $38.09K Beat $20.00K Estimate   Benzinga
12:08PM EST  Cormedix's Return On Capital Employed Insights   Benzinga
11:42AM EST  The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Nov 2, 2021
08:30AM EDT  CorMedix Inc. to Report Third Quarter 2021 Financial Results and   GlobeNewswire Inc
06:16AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 05.55 A.M. EDT).   RTTNews
Oct 20, 2021
08:33AM EDT  CorMedix Inc. Announces Abstracts At Upcoming Conferences   Benzinga
08:30AM EDT  CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing   GlobeNewswire Inc
Oct 4, 2021
04:02PM EDT  CorMedix CEO Khoso Baluch To Retire, Effective Oct. 4; Matt David, M.D. Appointed Interim CEO   Benzinga
04:01PM EDT  CorMedix Inc. Announces Executive Leadership Changes   GlobeNewswire Inc
Sep 30, 2021
11:19AM EDT  Cormedix's Return On Capital Employed Overview   Benzinga
08:02AM EDT  Antimicrobials Working Group Highlights Member Company Participation at IDWeek   PR Newswire
Sep 17, 2021
07:26PM EDT  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm   Business Wire
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 14, 2021
06:30PM EDT  Pomerantz Law Firm Announces the Filing of a Class Action Against CorMedix,   PR Newswire
Sep 7, 2021
02:32PM EDT  Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher   Benzinga
12:12PM EDT  Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump   Benzinga
10:11AM EDT  Mid-Morning Market Update: Markets Open Lower; Avantor To Acquire Masterflex   Benzinga
08:49AM EDT  CorMedix Says Was Informed By Contract Manufacturer That There Are Issues Unrelated To DefenCath Manufacturing Activities; Timeline For Co. and CMO To Address Deficiencies That Are Required For Resubmission Of DefenCath NDA Is Uncertain   Benzinga
08:30AM EDT  CorMedix Inc. Announces Regulatory Update   GlobeNewswire Inc
Aug 31, 2021
08:42PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Aug 12, 2021
04:27PM EDT  Cormedix Q2 EPS $(0.12) Beats $(0.17) Estimate   Benzinga
04:01PM EDT  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for the second quarter and six months ended June 30, 2021 and provided an update on recent developments.   GlobeNewswire Inc
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 3, 2021
05:33PM EDT  Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline - CRMD   PR Newswire
Jul 28, 2021
08:30AM EDT  CorMedix Inc. to Report Second Quarter 2021 Financial Results and   GlobeNewswire Inc
Jul 26, 2021
03:03PM EDT  SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Jul 23, 2021
08:00PM EDT  CORMEDIX ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm   Business Wire
04:27PM EDT  Gainey McKenna & Egleston announces that a class action lawsuit has been filed against CorMedix Inc. (CorMedix or the Company) (NASDAQ: CRMD) in the United States District Court for the District of New Jersey on behalf of those who purchased or otherwise acquired CorMedix publicly traded securities between July 8, 2020 and May 13, 2021, inclusive (the Class Period).   GlobeNewswire Inc
Jul 22, 2021
09:03PM EDT  Pomerantz Law Firm Announces the Filing of a Class Action Against CorMedix Inc.   PR Newswire
Jun 10, 2021
08:30AM EDT  CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits   GlobeNewswire Inc
Jun 9, 2021
08:30AM EDT  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will participate in a fireside chat at the JMP Securities Life Sciences Conference taking place on June 16 17, 2021.   GlobeNewswire Inc
May 20, 2021
08:27AM EDT  The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks   Benzinga
May 14, 2021
03:09PM EDT  Mid-Afternoon Market Update: Dow Jumps 400 Points; CorMedix Shares Slide   Benzinga
12:10PM EDT  Mid-Day Market Update: Crude Oil Rises 2%; CorMedix Shares Drop Following Q1 Results   Benzinga
10:13AM EDT  Mid-Morning Market Update: Markets Open Higher; Disney Sales Miss Expectations   Benzinga
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
06:55AM EDT  Needham Maintains Buy on Cormedix, Lowers Price Target to $29   Benzinga
May 13, 2021
05:43PM EDT  CORRECTION: Cormedix Q1 Sales $88.26K Miss $140.00K Estimate   Benzinga
05:43PM EDT  Cormedix Q1 EPS $(0.20) Misses $(0.18) Estimate, Sales $88.26K Miss $140.00K Estimate   Benzinga
04:26PM EDT  Cormedix Q1 EPS $(0.20) Misses $(0.18) Estimate, Sales $88.26M Beat $140.00K Estimate   Benzinga
04:01PM EDT  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for the first quarter ended March 31, 2021 and provided an update on recent business events.   GlobeNewswire Inc
08:30AM EDT  CorMedix Inc. Announces Appointment of Chief Commercial Officer   GlobeNewswire Inc
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 5, 2021
08:00AM EDT  CorMedix Inc. to Report First Quarter 2021 Financial Results and   GlobeNewswire Inc
Apr 28, 2021
08:30AM EDT  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will participate in investor meetings at the 7th Annual Truist Securities Life Sciences Summit taking place on May 4 5, 2021.   GlobeNewswire Inc
Apr 14, 2021
02:37PM EDT  Mid-Afternoon Market Update: Dow Gains Over 100 Points; Bed Bath & Beyond Shares Plummet   Benzinga
09:05AM EDT  CorMedix Say Met With FDA To Discuss Proposed Resolutions For Deficiencies In CRL For DefenCath NDA; Says There Is Agreed-Upon Protocol For Study FDA Is Requiring Confirmation Of In-Process Controls To Show Labeled Vol. Can Be Withdrawn From Vials   Benzinga
09:00AM EDT  CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA   GlobeNewswire Inc
Apr 7, 2021
08:30AM EDT  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference taking place on April 12 15, 2021.   GlobeNewswire Inc
Mar 30, 2021
04:11PM EDT  Cormedix Q4 EPS $(0.19) Beats $(0.22) Estimate, Sales $55.71K Beat $50.00K Estimate   Benzinga
04:05PM EDT  CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on recent business developments.   GlobeNewswire Inc
08:06AM EDT  The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings   Benzinga
04:04AM EDT  Earnings Scheduled For March 30, 2021   Benzinga
Mar 23, 2021
08:30AM EDT  CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020   GlobeNewswire Inc
Mar 15, 2021
08:41AM EDT  CorMedix Says Approved To Sell $1.3 Mln Of NOL Tax Benefits Through NJEDA   RTTNews
08:33AM EDT  CorMedix Approved to Sell $1.3M of NOL Tax Benefits Through The New Jersey Economic Development Authority Program   Benzinga
08:30AM EDT  CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through   GlobeNewswire Inc
Mar 11, 2021
08:30AM EST  CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt   GlobeNewswire Inc
Mar 9, 2021
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
Mar 8, 2021
05:00PM EST  CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will host a conference call relating to a regulatory update for DefenCath at 8:30am ET on March 9, 2021.   GlobeNewswire Inc
Mar 1, 2021
02:37PM EST  Mid-Afternoon Market Update: Crud Oil Down Over 1%; Morphic Shares Spike Higher   Benzinga
12:17PM EST  Mid-Day Market Update: Dow Jumps Over 600 Points; CorMedix Shares Plummet   Benzinga
10:13AM EST  Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Receives FDA Approval For COVID-19 Vaccine   Benzinga
08:55AM EST  FDA Strikes Out CorMedix's DefenCath Application   Benzinga
08:34AM EST  Cormedix Receives Complete Response Letter From FDA For DefenCath Catheter Lock Solution Indicating FDA Cannot Approve NDA In Present Form; FDA Noted Concerns At Third-Party Manufacturing Facility   Benzinga
08:30AM EST  CorMedix Receives Complete Response Letter From FDA for   GlobeNewswire Inc
Feb 17, 2021
10:12AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021   Benzinga
07:41AM EST  Needham Initiates Coverage On Cormedix with Buy Rating, Announces Price Target of $31   Benzinga
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
Feb 4, 2021
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
11:12AM EST  Truist Securities Maintains Buy on Cormedix, Raises Price Target to $35   Benzinga
08:05AM EST  The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment   Benzinga
Jan 31, 2021
05:22AM EST  Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates   Benzinga
Jan 21, 2021
08:38AM EST  CorMedix To Transfer Listing From NYSE American To Nasdaq, Effective Tuesday, Feb. 2, 2021   Benzinga
08:30AM EST  CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange   GlobeNewswire Inc
Nov 18, 2020
08:31AM EST  CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting For New Drug Application For Defencath Is Not Needed; PDUFA Date Remains February 28, 2021   Benzinga
08:30AM EST  -- PDUFA date remains February 28, 2021 -- Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients   GlobeNewswire Inc
Nov 17, 2020
03:23AM EST  Activist Investor Elliott Exits AT&T, Buys Uniti, Boosts Dell   Benzinga
Nov 6, 2020
07:54AM EST  Cormedix Inc Files For Mixed Shelf Of Up To $100M   Benzinga
Nov 5, 2020
05:22PM EST  Cormedix Q3 EPS $(0.22) Beats $(0.25) Estimate, Sales $93.02K Beat $40.00K Estimate   Benzinga
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 2, 2020
08:30AM EST  CorMedix Appoints Greg Duncan to its Board of Directors   GlobeNewswire Inc
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
08:30AM EDT  CorMedix Inc. to Report Third Quarter 2020 Financial Results and   GlobeNewswire Inc
Oct 8, 2020
09:00AM EDT  CorMedix to Participate in BIO Investor Forum Digital   GlobeNewswire Inc
Sep 29, 2020
06:20AM EDT  JMP Securities Initiates Coverage On Cormedix with Market Outperform Rating, Announces Price Target of $22   Benzinga
Sep 21, 2020
11:22AM EDT  Why Cormedix's Stock Is Trading Higher Today   Benzinga
07:15AM EDT  Truist Securities Initiates Coverage On Cormedix with Buy Rating, Announces Price Target of $20   Benzinga
Sep 17, 2020
08:30AM EDT  CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced the appointment of Paulo F. Costa to its Board of Directors.   GlobeNewswire Inc
Sep 9, 2020
08:30AM EDT  CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global   GlobeNewswire Inc
Sep 4, 2020
11:28AM EDT  Insider Buys CorMedix's Stock   Benzinga
Aug 31, 2020
07:53AM EDT  Cormedix Shares Spike Higher, Up 14%, After Co Announces FDA Acceptance For Filing, Priority Review Of New Drug Application For Defencath   Benzinga
07:49AM EDT  CorMedix Announces FDA Acceptance For Filing, Priority Review Of New Drug Application For Defencath; Sets PDUFA Goal Date of Feb. 28, 2021   Benzinga
07:48AM EDT  -- FDA sets PDUFA goal date of February 28, 2021 -- Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients   GlobeNewswire Inc
Aug 20, 2020
05:58PM EDT  CorMedix Director Khan Mehmood Buys 45,750 @ Avg Price: $4.84   Benzinga
Aug 11, 2020
06:58AM EDT  HC Wainwright & Co. Maintains Buy on Cormedix, Lowers Price Target to $10   Benzinga
Aug 10, 2020
04:14PM EDT  Cormedix Q2 EPS $(0.14), Inline, Sales $16.44M Up From $35.27K YoY   Benzinga
04:06PM EDT  CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for the second quarter and six months ended June 30, 2020 and provided an update on recent developments.   GlobeNewswire Inc
08:41AM EDT  Elliott Investment Management L.P. Reports Stake Of 5.8% Of CorMedix Inc As Of July 30, 2020   Benzinga
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga
Aug 7, 2020
11:10AM EDT  Cormedix's Earnings: A Preview   Benzinga
Aug 3, 2020
04:05PM EDT  CorMedix Inc. to Report Second Quarter 2020 Financial Results and   GlobeNewswire Inc
Jul 28, 2020
02:30PM EDT  Mid-Afternoon Market Update: Vocera Communications Surges On Upbeat Q2 Results; Nemaura Medical Shares Slide   Benzinga
09:22AM EDT  CorMedix Prices 4.44M Share Offering At $4.50/Share   Benzinga
09:21AM EDT  CorMedix Announces Pricing of $20M Public Offering of Common Stock   GlobeNewswire Inc
Jul 27, 2020
04:05PM EDT  CorMedix Announces A Common Stock Offering; No Size Disclosed   Benzinga
04:05PM EDT  CorMedix Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC